Literature DB >> 2250299

History of cigarette smoking and risk of leukemia and myeloma: results from the Adventist health study.

P K Mills1, G R Newell, W L Beeson, G E Fraser, R L Phillips.   

Abstract

The risks of leukemia and myeloma associated with cigarette smoking were evaluated in a cohort study of 34,000 Seventh-day Adventists. Although Seventh-day Adventists do not smoke by church proscription, many are adult converts who smoked cigarettes prior to their baptism into the church. In comparison with those who never smoked, ex-smokers experience a relative risk of 2.00 (95% confidence interval = 1.01-3.95) for leukemia and 3.01 (95% confidence interval = 1.13-8.05) for myeloma. Risks increased in a dose-response fashion with increasing numbers of cigarettes smoked daily for both leukemia (trend P = .009) and myeloma (trend P = .005). Also, the risks of both leukemia and myeloma increased with the total duration of cigarette smoking. The cigarette smoking-leukemia relationship was strongest for myeloid leukemia, for which ex-smokers experienced a relative risk of 2.24 (95% confidence interval = 0.91-5.53). These data lend support to the hypothesis that cigarette smoke may induce malignant degeneration in bone marrow and its products.

Entities:  

Mesh:

Year:  1990        PMID: 2250299     DOI: 10.1093/jnci/82.23.1832

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

1.  Smoking and risk of non-Hodgkin's lymphoma and multiple myeloma.

Authors:  L M Brown; G D Everett; R Gibson; L F Burmeister; L M Schuman; A Blair
Journal:  Cancer Causes Control       Date:  1992-01       Impact factor: 2.506

2.  Smoking and multiple myeloma.

Authors:  L J Herrinton; T D Koepsell; N S Weiss
Journal:  Cancer Causes Control       Date:  1992-07       Impact factor: 2.506

3.  Cigarette smoking and leukemia: results from the Lutheran Brotherhood Cohort Study.

Authors:  M S Linet; J K McLaughlin; A W Hsing; S Wacholder; H T Co-Chien; L M Schuman; E Bjelke; W J Blot
Journal:  Cancer Causes Control       Date:  1991-11       Impact factor: 2.506

4.  Lymphohaematopoietic malignancies and quantitative estimates of exposure to benzene in Canadian petroleum distribution workers.

Authors:  A R Schnatter; T W Armstrong; M J Nicolich; F S Thompson; A M Katz; W W Huebner; E D Pearlman
Journal:  Occup Environ Med       Date:  1996-11       Impact factor: 4.402

5.  Regulation of p53-targeting microRNAs by polycyclic aromatic hydrocarbons: Implications in the etiology of multiple myeloma.

Authors:  Michael W Gordon; Fang Yan; Xiaoming Zhong; Pranab Behari Mazumder; Zijun Y Xu-Monette; Dehui Zou; Ken H Young; Kenneth S Ramos; Yong Li
Journal:  Mol Carcinog       Date:  2014-05-06       Impact factor: 4.784

6.  A prospective study of tobacco use and multiple myeloma: evidence against an association.

Authors:  E F Heineman; S H Zahm; J K McLaughlin; J B Vaught; Z Hrubec
Journal:  Cancer Causes Control       Date:  1992-01       Impact factor: 2.506

7.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces peripheral blood abnormalities and plasma cell neoplasms resembling multiple myeloma in mice.

Authors:  Lei Wang; Munish Kumar; Qipan Deng; Xu Wang; Ming Liu; Zhaojian Gong; Shanshan Zhang; Xiaodong Ma; Zijun Y Xu-Monette; Min Xiao; Qing Yi; Ken H Young; Kenneth S Ramos; Yong Li
Journal:  Cancer Lett       Date:  2018-10-19       Impact factor: 8.679

Review 8.  The dichotomy of p53 regulation by noncoding RNAs.

Authors:  Qipan Deng; Lindsey Becker; Xiaodong Ma; Xiaoming Zhong; Ken Young; Kenneth Ramos; Yong Li
Journal:  J Mol Cell Biol       Date:  2014-04-04       Impact factor: 6.216

Review 9.  Does benzene cause multiple myeloma? An analysis of the published case-control literature.

Authors:  S Bezabeh; A Engel; C B Morris; S H Lamm
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

10.  Clustering of cancer among families of cases with Hodgkin Lymphoma (HL), Multiple Myeloma (MM), Non-Hodgkin's Lymphoma (NHL), Soft Tissue Sarcoma (STS) and control subjects.

Authors:  Helen H McDuffie; Punam Pahwa; Chandima P Karunanayake; John J Spinelli; James A Dosman
Journal:  BMC Cancer       Date:  2009-02-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.